Cubicin recalled due to foreign particulate matter contamination
Certain lots of Cubicin 500 mg in 10 mL single-use vials have been voluntarily recalled by manufacturer Cubist Pharmaceuticals. The recall comes after numerous reports that the drug may contain life-threatening foreign particulate matter, Market Watch reported on Sunday, August 10.
Reconstituted vials of the antibacterial injection with lot numbers CDC 203, CDC 207, CDC 213, CDC 217, CDC 226, CDC 234, CDC 235, CDC 243, and CDC 246 are all affected by the nationwide recall. Consumers are instructed to return the product for replacement.
Recall promoters argue that administering injectable drugs with traces of foreign matter poses great health risk among its users, including pulmonary embolism and phlebitis.
The medical and financial consequences of an injury caused by a defective pharmaceutical product can be overwhelmingly distressing. To learn more about seeking compensation when hurt by a defective medical product in Detroit, consult with our team of dedicated product liability attorneys at Ravid & Associates, P.C., by calling (248) 948-9696 today.